Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.

Literature DB >> 1318359

Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.

Abstract

A 59 year old man with ischaemic heart disease, developed the clinical and electromyographic changes of the Lambert-Eaton myasthenic syndrome after taking calcium antagonist, diltiazem. The symptoms appeared periodically with a rise and fall in serum level of diltiazem. Extensive search was made for systemic neoplasms and autoimmune diseases without success. Serum antibody to voltage operated calcium channel was not detected.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1992 PMID： 1318359 PMCID： PMC489088 DOI： 10.1136/jnnp.55.5.409

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

11 in total

1. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.

Authors: E Sher; C Gotti; N Canal; C Scoppetta; G Piccolo; A Evoli; F Clementi
Journal: Lancet Date: 1989-09-16 Impact factor: 79.321

Review 2. Multiple types of neuronal calcium channels and their selective modulation.

Authors: R W Tsien; D Lipscombe; D V Madison; K R Bley; A P Fox
Journal: Trends Neurosci Date: 1988-10 Impact factor: 13.837

3. The Eaton-Lambert (myasthenic) syndrome in association with systemic lupus erythematosus.

Authors: R L Hughes; M B Katirji
Journal: Arch Neurol Date: 1986-11

4. [Eaton-Lambert syndrome manifested by respiratory failure associated with small cell carcinoma of the lung].

Authors: A Yamada; H Takeuchi; T Touge; H Miki; H Kuwabara
Journal: Rinsho Shinkeigaku Date: 1990-07

5. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.

Authors: C Peers; B Lang; J Newsom-Davis; D W Wray
Journal: J Physiol Date: 1990-02 Impact factor: 5.182

6. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.

Authors: B Lang; J Newsom-Davis; D Wray; A Vincent; N Murray
Journal: Lancet Date: 1981-08-01 Impact factor: 79.321

7. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

Authors: H Fukunaga; A G Engel; B Lang; J Newsom-Davis; A Vincent
Journal: Proc Natl Acad Sci U S A Date: 1983-12 Impact factor: 11.205

Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.

1. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.

Review 2. Multiple types of neuronal calcium channels and their selective modulation.

3. The Eaton-Lambert (myasthenic) syndrome in association with systemic lupus erythematosus.

4. [Eaton-Lambert syndrome manifested by respiratory failure associated with small cell carcinoma of the lung].

5. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.

6. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.

7. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

8. Effects of diltiazem and verapamil on responses to acetylcholine.

9. The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

10. Autoimmunity in the Lambert-Eaton myasthenic syndrome.

1. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.

Review 2. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.